OptiBiotix, a leading developer of compounds to tackle obesity, cardiovascular disease and diabetes, has announced the launch of WellBiome – a revolutionary functional fibre and mineral blend specifically targeted for the health and well-being market.
According to research carried out by Attest in the UK Health & Wellbeing Report 2020, almost two thirds (64%) of UK consumers want to improve their physical health, whereas nearly half (42%) want to change their eating habits by selecting less processed food options.
With health and wellness front of mind for many consumers, the latest innovation from OptiBiotix uses microbiome modulating science to support those looking to achieve a healthier lifestyle.
Developed by leading UK universities and key opinion leaders on the gut microbiome and functional food ingredients, WellBiome has been formulated to support the growth of beneficial bacteria and improve overall well-being.
The lactose and gluten-free ingredients found in WellBiome work in synergy by harnessing the health positive bacteria found in the gut microbiome to deliver real benefits in digestive, heart and metabolic health. In addition, WellBiome is also suitable for vegans.
Dr Frederic Narbel, Managing Director of Functional Fibres at OptiBiotix, said: “We are pleased to unveil our new revolutionary ingredient which joins the OptiBiotix ingredients portfolio."
"As consumer awareness of the gut microbiome increases, products that contain functional fibres that support health and well-being are becoming increasingly popular. With the microbiome modulating WellBiome, our partners can now extend their reach into the exciting health and well-being market with a science-backed offering.”
Having demonstrated its efficacy in controlled human studies, WellBiome’s patented formulation has shown that it is an effective way to support improved health and well-being in three primary areas.
The prebiotic helps to maintain a healthy digestive system and supports regular bowel habits by significantly increasing essential bacteria – including the Bifidobacterium, Bacteroides and Christensenella strains – owing to its high soluble fibre content (94%).
In addition, scientific studies have demonstrated WellBiome can regulate glycaemic response to support metabolic health and significantly reduce systolic blood pressure.
The revolutionary ingredient also supports several EFSA health claims, including the use of chromium which contributes to the maintenance of normal blood glucose levels and glucomannan which reduces blood cholesterol.
“The Health and Wellness industry is estimated to be worth $4.2 trillion in 2019, with the digestive health segment accounting for $60 billion,” adds Dr Narbel.
“For OptiBiotix, the development of WellBiome is a direct response to the trends that are dominating the industry today. As a leading life sciences company that excels in delivering science-backed ingredients, we are helping to combat the health challenges of today, tomorrow and the near future."
"WellBiome is a major part of this journey and will help play a key role in the livelihoods of consumers by improving digestive, heart and metabolic health.”